L. Wooten

Monitoring event times in early phase clinical trials: some practical issues

Peter F Thall, P. Thall, N. Tannir, 2005, Clinical trials.

Bayesian and frequentist two‐stage treatment strategies based on sequential failure times subject to interval censoring

Peter F Thall, P. Thall, R. Millikan, 2007, Statistics in medicine.

A phase II trial of gemcitabine plus capecitabine for metastatic renal cell cancer previously treated with immunotherapy and targeted agents.

P. Thall, E. Jonasch, C. Wood, 2008, The Journal of urology.